RBM20 and cardiomyopathy: In a study of a family with RBM20 cardiomyopathy caused by an E913K mutation in RBM20, protein levels of RBM20 were strongly reduced, while mRNA levels and stability were not, which may suggest that the new lysine functions as a substrate for ubiquitination, and leads to degradation by the proteasomal complex [23].